Pellets

Pellestisation is an agglomeration process, that converts fine powder-blend(s) & excipients into small-free flowing, spherical units referred to as PELLETS.

 

WHY PELLETS SHOULD BE PREFERRED

  • Excellent stability
  • Compact structure
  • Drug absorption
  • Release of action at specially targeted site
  • High active ingredient content possible
  • Controlled release application
  • These pellets avoid local irritation of GASTRO INTESTINAL TRACT(GIT) because the drugs doesn’t settle down at one place
ANTI-ALLERGIC
PRODUCT COMPOSITION
ANTI ALLERGIC  
CETIRIZINE HYDROCHLORIDE 15%W/W PELLETS 15%
ANTI-BACTERIAL AGENT
PRODUCT COMPOSITION
ANTI BACTERIAL AGENT  
MINOCYCLINE HYDROCHLORIDE 35% W/W PELLETS 35%
ANTI-CONVULSANT/ENZYME INHIBITOR
PRODUCT COMPOSITION
ANTI CONVULSANT/ENZYME INHIBITOR  
VALPROIC ACID 58mg,87mg
SODIUM VALPORATE 133mg,200mg
ANALGESIC
PRODUCT COMPOSITION
Analgesic  
ACECLOFENAC SODIUM 60% W/W SUSTAINED RELEASE PELLETS(FOR DOMESTIC & EXPORT) 60%
ACECLOFENAC SODIUM 40% W/W SUSTAINED RELEASE PELLETS(FOR DOMESTIC & EXPORT) 40%
DICLOFENAC SODIUM PELLET 40% w/w IN SUSTAINES RELEASE FORM 40%
DICLOFENAC POTASSIUM 50% W/W EXTENDED RELEASE PELL 50%
INDOMETHACIN EXTENDED RELEASE 30% W/W PELLETS 30%
ANTI-DEPRESANT
PRODUCT COMPOSITION
ANTI DEPRESANT  
VENLAFAXINE HYDROCHLORIDE 25% SR 25%
DULOXETINE HYDROCHLORIDE 10 % W/W ENTERIC COATED PELLETS 10%
ANTI-EMETIC
PRODUCT COMPOSITION
ANTI-EMETIC  
DOMPERIDONE(SUSTAINED RELEASE) PELLETS 20 mg
DOMPERIDONE(IMMEDIATE RELEASE) PELLETS 10 mg
DOMPERIDONEPELLETS (SUSTAINED RELEASE) 30mg
ANTI-FUNGAL AGENTS
PRODUCT COMPOSITION
Antifungal Agents  
ITRACONAZOLE PELLETS 22% W/W 22%
ANTI-PLATELET
PRODUCT COMPOSITION
Anti-platelet  
CLOPIDOGREL PELLETS 75 MG 75mg
CLOPIDROGREL PELLETS 50% W/W, 55% W/W 50,55%
ASPRIN 28% w/w, 60% w/w  
ROSUVASTATIN 10mg(IR) PELLETS  
ANTI-SPASMODIC
PRODUCT COMPOSITION
ANTI SPASMODIC  
MEBEVERINE HYDROCHLORIDE 40% W/W SR PELLETS 40%
ANTI-ULCERANT
PRODUCT COMPOSITION
Anti-ulcerant  
OMEPRAZOLE ENTERIC COATED PELLETS 8.5% W/W 8.50%
OMEPRAZOLE ENTERIC COATED PELLETS 15.0% W/W 15%
LANSOPRAZOLE ENTERIC COATED PELLETS 8.5% W/W 8.50%
LANSOPRAZOLE ENTERIC COATED PELLETS 10.0% W/W 10%
PANTOPRAZOLE ENTERIC COATED PELLETS 40mg 40mg
RABEPRAZOLE ENTERIC COATED PELLETS 20 MG 20mg
ESOMEPRAZOLE ENTERIC COATED PELLETS 40 MG 40mg
ESOMEPRAZOLE ENTERIC COATED PELLETS 20 MG 20mg
CARDIO VASCULAR
PRODUCT COMPOSITION
Cardio Vascular  
ATORVASTATIN PELLETS 10MG, 20MG 10,20mg
EXPECTORANT
PRODUCT COMPOSITION
EXPECTORANT  
AMBROXOL HYDROCHLORIDE 40% W/W PELLETS 40%
GOUTSUPRESSANT, ENZYME INHIBITOR, ANTI METABOLITE
PRODUCT COMPOSITION
GOUTSUPRESSANT, ENZYME INHIBITOR, ANTI METABOLITE  
ALLOPURINOL 70% W/W SUSTAINED RELEASE PELLETS 70%
HYPOLIPIDEMIC AGENT
PRODUCT COMPOSITION
HYPOLIPIDEMIC AGENT  
FENOFIBRATE 66% W/W PELLETS 66%
PREMATURE EJACULATION
PRODUCT COMPOSITION
Premature Ejaculation  
DAPOXETINE HYDROCHLORIDE 11% , 22% W/W 11,22%
PROKINETIC AGENT
PRODUCT COMPOSITION
Prokinetic agent  
ITOPRIDE HCL SR PELLETS 150 MG 150mg
PROTONPUMP INHIBITOR
PRODUCT COMPOSITION
PROTONPUMP INHIBITOR  
DEXLANSOPRAZOLE 20% W/W PELLETS 20%
DEXRABEPRAZOLE 20% W/W PELLETS 20%